Ignite Creation Date:
2025-12-24 @ 7:39 PM
Ignite Modification Date:
2026-01-02 @ 10:52 AM
Study NCT ID:
NCT06622603
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-10-02
First Post:
2024-09-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Effects of Febuxostat Dose Tapering in Gout Patients Optimally Controlled for 5 Years or More
Sponsor:
Seoul National University Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TARGET-V1-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None